Rico International focuses on introducing Japanese medicines into China

 瑞科国际(北京)医药技术有限公司

 

Expired patent drugs

Although Japan is a big country with patented drugs, there are many generic drugs. The introduction of characteristic generic drugs can be a supplement to the Chinese market.

 瑞科国际(北京)医药技术有限公司

 

Patent medicine

Introduce patented new drugs to fill the gaps in the Chinese market and shorten the gap between China and the advanced level.

 瑞科国际(北京)医药技术有限公司

 

Joint development

Early participation in product development in Japan; participation in international multi-center research, allowing new products to be launched simultaneously in China and the world.

 瑞科国际(北京)医药技术有限公司

 

Early development buyout

There are many projects under study in Japan that require external funding. China can use its capital advantage to purchase projects under study and obtain patent rights.

 瑞科国际(北京)医药技术有限公司

Maintain good communication with Japan PMDA

Become a strategic partner with more than 50 Japanese pharmaceutical companies and scientific research institutions 

Domestic partners

PARTNERS

葵花药业
更多 白箭头 黑箭头
西藏海容
更多 白箭头 黑箭头
cooperative partner
更多 白箭头 黑箭头
纳肽得医药
更多 白箭头 黑箭头
亚宝药业
更多 白箭头 黑箭头
珍寳岛药业
更多 白箭头 黑箭头
莱美药业
更多 白箭头 黑箭头
天津药物研究院
更多 白箭头 黑箭头
康森药业
更多 白箭头 黑箭头
上海医药
更多 白箭头 黑箭头
罗欣药业
更多 白箭头 黑箭头
扬子江药业集团
更多 白箭头 黑箭头

Foreign partners

PARTNERS

客户留言
code

Rico International (Beijing) Medicine Technology Co., Ltd.

Add:   Room 709, Building 10, Wanda Plaza, No. 93, Jianguo Road, Chaoyang District, Beijing

Rico International (Beijing) Medicine Technology Co., Ltd.    copyright ©2020       京ICP备2020042821号

瑞科国际(北京)医药技术有限公司